NCT04329403View on ClinicalTrials.gov

Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1%

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2020

Primary Completion Date

January 31, 2021

Study Completion Date

May 31, 2021

Conditions
Acne Vulgaris
Interventions
DRUG

Adapalene 0.1% Gel

A thin film of the assigned medication to be applied once daily in the evening for 12 weeks

DRUG

Differin 0.1% Topical Gel

A thin film of the assigned medication to be applied once daily in the evening for 12 weeks

OTHER

Placebo

A thin film of the assigned medication to be applied once daily in the evening for 12 weeks

Sponsors
All Listed Sponsors
lead

Aurobindo Pharma Ltd

INDUSTRY

NCT04329403 - Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1% | Biotech Hunter | Biotech Hunter